InduPro raises $77M, begins first human trial of cancer drug

https://cdn.geekwire.com/wp-content/uploads/2026/08/InduPro.png" width="1114" />
Seattle biotech InduPro has raised $77 million and dosed its first patient in a Phase 1 trial of an experimental cancer drug, as the company advances its novel approach to targeting tumor cells. https://www.geekwire.com/2026/indupro-raises-77m-begins-first-human-trial-of-cancer-drug/">Read More